200 related articles for article (PubMed ID: 2433970)
1. Pharmacokinetics of N-acetylprocainamide.
Atkinson AJ; Ruo TI
Angiology; 1986 Dec; 37(12 Pt 2):959-67. PubMed ID: 2433970
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the pharmacokinetic and pharmacodynamic properties of procainamide and N-acetylprocainamide.
Atkinson AJ; Ruo TI; Piergies AA
Angiology; 1988 Jul; 39(7 Pt 2):655-67. PubMed ID: 2457345
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic studies of procainamide (PA) and N-acetylprocainamide (NAPA) in healthy subjects.
Wierzchowiecki M; Michałowska D; Lowicki Z; Ochotny R; Grześkowiak A; Tomaszkiewicz T
Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):272-6. PubMed ID: 6161089
[TBL] [Abstract][Full Text] [Related]
4. Bioavailability of N-acetylprocainamide from mixed diet in rats.
Kamath BL; Yacobi A; Gupta SD; Stampfli H; Durrani M; Lai CM
Res Commun Chem Pathol Pharmacol; 1981 May; 32(2):299-308. PubMed ID: 6166034
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of procainamide hydrochloride in dogs.
Papich MG; Davis LE; Davis CA; McKiernan BC; Brown SA
Am J Vet Res; 1986 Nov; 47(11):2351-8. PubMed ID: 2431636
[TBL] [Abstract][Full Text] [Related]
6. Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: comparison with procainamide.
Roden DM; Reele SB; Higgins SB; Wilkinson GR; Smith RF; Oates JA; Woosley RL
Am J Cardiol; 1980 Sep; 46(3):463-8. PubMed ID: 6158263
[TBL] [Abstract][Full Text] [Related]
7. Effect of coronary artery ligation on the pharmacokinetics of N-acetylprocainamide in dogs.
Lai CM; Reynolds RD; Kamath BL; Calzadilla S; Gupta SD; Look ZM; Yacobi A
Res Commun Chem Pathol Pharmacol; 1980 Aug; 29(2):369-72. PubMed ID: 6158076
[TBL] [Abstract][Full Text] [Related]
8. Arrhythmia control by selective lengthening of cardiac repolarization: role of N-acetylprocainamide, active metabolite of procainamide.
Singh BN; Feld G; Nademanee K
Angiology; 1986 Dec; 37(12 Pt 2):930-8. PubMed ID: 2433967
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacokinetics of N-acetylprocainamide.
Connolly SJ; Kates RE
Clin Pharmacokinet; 1982; 7(3):206-20. PubMed ID: 6178545
[TBL] [Abstract][Full Text] [Related]
10. Disposition of procainamide and N-acetylprocainamide in protein-calorie malnutrition.
Jung D; Nanavaty M; Prasad P
Drug Metab Dispos; 1985; 13(3):359-63. PubMed ID: 2410212
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic and pharmacodynamic interaction of N-acetyl procainamide and procainamide in humans.
Funck-Brentano C; Light RT; Lineberry MD; Wright GM; Roden DM; Woosley RL
J Cardiovasc Pharmacol; 1989 Sep; 14(3):364-73. PubMed ID: 2476614
[TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacology and antiarrhythmic efficacy of N-acetylprocainamide.
Winkle RA; Jaillon P; Kates RE; Peters F
Am J Cardiol; 1981 Jan; 47(1):123-30. PubMed ID: 6161534
[TBL] [Abstract][Full Text] [Related]
13. [New anti-arrhythmia drug. III. Comparative studies of the effects of N-propionylprocainamide, procainamide and N-acetylprocainamide on hemodynamics and cardiac blood flow].
Kusowska J; Polakowski P
Acta Pol Pharm; 1989; 46(2):187-94. PubMed ID: 2483600
[TBL] [Abstract][Full Text] [Related]
14. Tissue distribution of N-acetylprocainamide in rats.
Yacobi A; Stampfli HF; Lai CM; Kamath BL
Drug Metab Dispos; 1981; 9(3):193-5. PubMed ID: 6166443
[TBL] [Abstract][Full Text] [Related]
15. The quantitative disposition of procainamide and N-acetylprocainamide in the rat.
Schneck DW; Grove K; Dewitt FO; Shiroff RA; Hayes AH
J Pharmacol Exp Ther; 1978 Jan; 204(1):219-25. PubMed ID: 619132
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetics of procainamide and its metabolite depending on acetylator phenotype].
Gawrońska-Szklarz B; Górnik W; Kutrzeba J; Wójcicki J; Zakrzewski J
Pol Tyg Lek; 1992 Oct 5-12; 47(40-41):921-3. PubMed ID: 1284448
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiologic evaluation of the antiarrhythmic effects of N-acetylprocainamide for ventricular tachycardia secondary to coronary artery disease.
Wynn J; Miura DS; Torres V; Flowers D; Keefe D; Williams S; Somberg JC
Am J Cardiol; 1985 Nov; 56(13):877-81. PubMed ID: 2414983
[TBL] [Abstract][Full Text] [Related]
18. Circadian changes in procainamide and N-acetylprocainamide kinetics in the rat.
Bruguerolle B; Jadot G
J Pharm Pharmacol; 1985 Sep; 37(9):654-6. PubMed ID: 2416904
[TBL] [Abstract][Full Text] [Related]
19. N-Acetylprocainamide kinetics and clinical response during repeated dosing.
Rodman JH; Hurst A; Gaarder T; Cohen J; Jelliffe RW
Clin Pharmacol Ther; 1982 Sep; 32(3):378-86. PubMed ID: 6179685
[TBL] [Abstract][Full Text] [Related]
20. Procainamide, N-acetylprocainamide, antinuclear antibody and systemic lupus erythematosus.
Reidenberg MM; Drayer DE
Angiology; 1986 Dec; 37(12 Pt 2):968-71. PubMed ID: 2433971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
